Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis

First author

Year

Country

Tumor type

Sample size

(n)

Gender

(Male/Female)

(n)

LINC00511 expression

(High/low)

(n)

Detection method

Tumor stage

Cut-off value

Survival analysis

Outcome

Quality score

Data extraction method

Sun C.-C.

2016

China

NSCLC

124

58/66

93/31

qRT-PCR

I-IV

P25 value

Univariate/Multivariate

OS/CP

8

Direct

Zhao X.

2017

China

PDAC

140

78/62

102/38

qRT-PCR

I-III

Not available

Univariate/Multivariate

OS/PFS/CP

7

Direct

Lu G.

2018

China

BC

39

0/39

23/16

qRT-PCR

I-IV

Mean

Kaplan-Meier

OS/CP

7

Indirect

Mao B.-D.

2019

China

CC

84

0/84

49/35

qRT-PCR

I1a-II2b

Median (0.996)

Kaplan-Meier

OS/RFS/CP

7

Indirect

Wang R.-P.

2019

China

HCC

127

76/51

64/63

qRT-PCR

I-IV

Median

Univariate/Multivariate

OS/CP

8

Direct

Zhang J.

2019

China

BC

70

0/70

24/46

qRT-PCR

I-IV

Mean

Kaplan-Meier

OS/CP

8

Indirect

Liu L.

2019

China

BC

98

0/98

49/49

qRT-PCR

I-IV

Median

Kaplan-Meier

OS/CP

7

Indirect

Yu C.-L.

2019

China

CC

92

0/92

46/46

qRT-PCR

I-IV

Not available

Univariate/Multivariate

OS/CP

8

Direct

Deng H.

2019

China

ccRCC

49

21/28

25/24

qRT-PCR

I-IV

Median

Kaplan-Meier

OS/CP

6

Indirect

Zhu F.-Y.

2019

China

NSCLC

57

28/29

29/28

qRT-PCR

I-IV

Median

Kaplan-Meier

OS/CP

8

Direct

Du X.

2019

China

GBM

36

24/12

18/18

qRT-PCR

Not available

Median

Kaplan-Meier

OS/PFS/CP

7

Indirect

Wang J.

2019

China

OC

378

Not available

189/189

qRT-PCR

Not available

Median

Univariate

OS

7

Direct

Wang Z.

2019

China

PC

177

Not available

134/43

RNA sequencing expression data

Not available

Not available

Kaplan-Meier

OS

7

Direct

Li C.

2019

China

GL

412

Not available

206/206

qRT-PCR

Not available

Not available

Kaplan-Meier

OS

6

Indirect

  1. Abbreviations: NSCLC Non-small-cell lung cancer, PDAC Pancreatic ductal adenocarcinoma, BC Breast cancer, CC Cervical cancer, HCC hepatocellular carcinoma, ccRCC Clear cell renal cell carcinoma, GBM Glioblastoma multiforme, OC Ovarian cancer, PC Pancreatic cancer, GL Glioma, qRT-PCR Quantitative real time polymerase chain, OS Overall survival, PFS Progression-free survival, RFS Relapse-free survival, DFS Disease-free survival, CP Clinicopathological parameters